Phase 1 Clinical Trials in Houston, Texas
5 recruitingHouston, Texas
Showing 1–5 of 5 trials
Recruiting
Phase 1
Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma
Phase 1Clear Cell CarcinomaGrowth Factor
M.D. Anderson Cancer Center30 enrolled1 locationNCT07072234
Recruiting
Phase 1
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
Refractory MelanomaPhase 1Recurrent Melanoma
M.D. Anderson Cancer Center39 enrolled1 locationNCT06660420
Recruiting
Phase 1
First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors
Solid Tumors (Phase 1)
Adcendo ApS180 enrolled7 locationsNCT07362888
Recruiting
Phase 1
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Kidney CancerPhase 1bHC-7366+1 more
M.D. Anderson Cancer Center35 enrolled1 locationNCT07401875
Recruiting
Phase 1
Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
RAS MutationSolid Tumors (Phase 1)
Adlai Nortye Biopharma Co., Ltd.91 enrolled2 locationsNCT07252479